Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders. (17th March 2016)

• Record Type: Journal Article
• Authors: Lee, Hyeong-Min; Kim, Yuna
• Other Names: San Luis Academic Editor.
• Is Part Of: Schizophrenia research and treatment. Volume 2016(2016)
• Publication Date: 2016-03-17
• Subjects: Schizophrenia -- Periodicals; Schizophrenia; Schizophrenia; Electronic journals; Periodicals; Periodicals; 616.898
• DOI: 10.1155/2016/6378137
• Languages: English
• ISSNs: 2090-2085

Abstract

Abstract : Better the drugs you know than the drugs you do not know. Drug repurposing is a promising, fast, and cost effective method that can overcome traditional de novo drug discovery and development challenges of targeting neuropsychiatric and other disorders. Drug discovery and development targeting neuropsychiatric disorders are complicated because of the limitations in understanding pathophysiological phenomena. In addition, traditional de novo drug discovery and development are risky, expensive, and time-consuming processes. One alternative approach, drug repurposing, has emerged taking advantage of off-target effects of the existing drugs. In order to identify new opportunities for the existing drugs, it is essential for us to understand the mechanisms of action of drugs, both biologically and pharmacologically. By doing this, drug repurposing would be a more effective method to develop drugs against neuropsychiatric and other disorders. Here, we review the difficulties in drug discovery and development in neuropsychiatric disorders and the extent and perspectives of drug repurposing.